Max Planck Institute for Experimental Medicine

Max Planck Institute of Experimental Medicine

Abbreviation	MPIEM
Predecessor	Kaiser Wilhelm Institute for Medical Research
Formation	1947 (1947)
Type	Scientific institute
Purpose	Research on experimental medicine in neuroscience
Headquarters	Göttingen, Lower Saxony, Germany
Key people	Klaus-Armin Nave, managing director
Parent organization	Max Planck Society
Website	(in English)

The Max Planck Institute of Experimental Medicine (Template:Lang-de) is located in Göttingen, Germany. It was founded as "Medizinische Forschungsanstalt der Kaiser-Wilhelm-Gesellschaft" (Medical Research Institution of the Kaiser Wilhelm Society) in 1947, and integrated into the Max-Planck Society in 1948. The institute was renamed to its current name in 1965. It is one of 80 institutes in the Max Planck Society (Max-Planck-Gesellschaft). Prof. Dr. Nils Brose is currently the acting director of the institute.

Research

The research focus of the institute is on neuroscience. Research activities cover a wide spectrum of topics, ranging from basic molecular analyses of neuronal processes to clinical studies on novel therapies of neurological and psychiatric disorders in patients. The central aim of all these studies is to understand basic molecular and cellular processes in brain function, to analyze their pathological dysfunction in psychiatric and neurological diseases, and ultimately to develop novel therapies for these disorders.

Departments

Neurogenetics

The Department of Neurogenetics, led by Klaus-Armin Nave, uses transgenic techniques, natural and engineered mouse mutants and the tools of molecular and cellular biology to study neural development and the pathomechanisms of neurodegenerative diseases. A major focus of their research is on neuron-glia interactions that result in the assembly of myelin in the nervous system. Neuronal processes (axons) exhibit signaling molecules that are recognized by Schwann cells and oligodendrocytes. These highly specialized glial cells wrap and electrically insulate axons in the peripheral and central nervous system, respectively. Myelin allows the fast propagation of electrical impulses, but glial cells are also required for axonal maintenance. This line of research helps us to understand the molecular mechanisms of human neurological diseases in which genetic mutations cause myelin loss and defects of motor and cognitive function.

Molecular Neurobiology

The Department of Molecular Neurobiology, led by Nils Brose, focuses on molecular mechanisms of synapse development and function in the mammalian central nervous system. For that purpose, Molecular Neurobiology is combining protein biochemical, yeast genetic, cell biological, electrophysiological and morphological methods with mouse genetics to identify and characterize key molecules with functional roles in synaptogenesis, presynaptic neurotransmitter release and postsynaptic signal transduction pathways. The final aim of these studies is a detailed molecular understanding of synaptogenesis and synaptic transmission, which in turn will be useful for the design of therapeutic strategies for neurological and psychiatric diseases that involve synaptic dysfunction.

Molecular Biology of Neuronal Signals

The Department of Molecular Biology of Neuron Signals, led by Walter Stühmer, investigates on structure-function relationships of native and genetically modified ion channels, on origin and distribution as well as on genetic and physiological regulation of expression of different ion channels and membrane proteins through in situ and in vitro methods. By combination of Total Internal Reflection Fluorescence Microscopy (TIRFM) with Fluorescence Resonance Energy Transfer (FRET) methods protein interactions at cell membranes are studied. In the focus of the research team is the analysis of physiological functions of ion channels during neuronal interactions and development and during cancerogenesis.

External links

• Homepage
• Homepage (in German)